{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:25:44Z","timestamp":1749183944161},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key R&D in Hainan Province","award":["ZDYF2022SHFZ118"],"award-info":[{"award-number":["ZDYF2022SHFZ118"]}]},{"name":"Hainan Province 'Nanhai Xinxing' Medical and Health Talent Platform Project and Research Fund of Hainan Cancer Hospital","award":["2023ZD05"],"award-info":[{"award-number":["2023ZD05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01105-7","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T14:21:11Z","timestamp":1722262871000},"page":"1505-1521","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nanofiber-based delivery of evodiamine impedes malignant properties of intrahepatic cholangiocarcinoma cells by targeting HDAC4 and restoring TPM1 transcription"],"prefix":"10.1007","volume":"37","author":[{"given":"Rui","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenming","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunchun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"issue":"3","key":"1105_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1105_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.soc.2019.06.002","volume":"28","author":"R El-Diwany","year":"2019","unstructured":"El-Diwany R, Pawlik TM, Ejaz A. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2019;28(4):587\u201399.","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"1105_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1105_CR4","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729245","volume":"24","author":"NN Massarweh","year":"2017","unstructured":"Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729245.","journal-title":"Cancer Control"},{"issue":"5","key":"1105_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/cco.2018.07.03","volume":"7","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52.","journal-title":"Chin Clin Oncol"},{"key":"1105_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fendo.2020.00189","volume":"11","author":"L Su","year":"2020","unstructured":"Su L, Zhang X, Zheng L, Wang M, Zhu Z, Li P. Mutation of isocitrate dehydrogenase 1 in cholangiocarcinoma impairs tumor progression by inhibiting isocitrate metabolism. Front Endocrinol (Lausanne). 2020;11:189.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1105_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13046-020-01741-5","volume":"39","author":"ZB Jiang","year":"2020","unstructured":"Jiang ZB, Huang JM, Xie YJ, Zhang YZ, Chang C, Lai HL, et al. Evodiamine suppresses non-small cell lung cancer by elevating CD8(+) T cells and downregulating the MUC1-C\/PD-L1 axis. J Exp Clin Cancer Res. 2020;39(1):249.","journal-title":"J Exp Clin Cancer Res"},{"key":"1105_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.797605","volume":"12","author":"M Wang","year":"2021","unstructured":"Wang M, Zhou B, Cong W, Zhang M, Li Z, Li Y, et al. Amelioration of AOM\/DSS-induced murine colitis-associated cancer by evodiamine intervention is primarily associated with gut microbiota-metabolism-inflammatory signaling axis. Front Pharmacol. 2021;12: 797605.","journal-title":"Front Pharmacol"},{"key":"1105_CR9","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.2147\/CMAR.S238093","volume":"12","author":"S Yang","year":"2020","unstructured":"Yang S, Chen J, Tan T, Wang N, Huang Y, Wang Y, et al. Evodiamine exerts anticancer effects against 143B and MG63 cells through the Wnt\/beta-Catenin signaling pathway. Cancer Manag Res. 2020;12:2875\u201388.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"1105_CR10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3390\/ijms23031855","volume":"23","author":"UJ Yun","year":"2022","unstructured":"Yun UJ, Bae SJ, Song YR, Kim YW. A critical YAP in malignancy of HCC is regulated by evodiamine. Int J Mol Sci. 2022;23(3):1855.","journal-title":"Int J Mol Sci"},{"key":"1105_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biocel.2019.01.012","volume":"108","author":"B Zhu","year":"2019","unstructured":"Zhu B, Zhao L, Liu Y, Jin Y, Feng J, Zhao F, et al. Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma. Int J Biochem Cell Biol. 2019;108:98\u2013110.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1105_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006920","volume":"5","author":"MD Kertai","year":"2015","unstructured":"Kertai MD, Li YJ, Li YW, Ji Y, Alexander J, Newman MF, et al. Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery. BMJ Open. 2015;5(5): e006920.","journal-title":"BMJ Open"},{"key":"1105_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2019.109013","volume":"182","author":"J Luo","year":"2020","unstructured":"Luo J, Li H, Deziel NC, Huang H, Zhao N, Ma S, et al. Genetic susceptibility may modify the association between cell phone use and thyroid cancer: a population-based case-control study in Connecticut. Environ Res. 2020;182: 109013.","journal-title":"Environ Res"},{"issue":"2","key":"1105_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/hep.29328","volume":"67","author":"CL Tsai","year":"2018","unstructured":"Tsai CL, Liu WL, Hsu FM, Yang PS, Yen RF, Tzen KY, et al. Targeting histone deacetylase 4\/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice. Hepatology. 2018;67(2):586\u201399.","journal-title":"Hepatology"},{"key":"1105_CR15","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.12659\/MSM.907340","volume":"24","author":"Y Chen","year":"2018","unstructured":"Chen Y, Hong Z, Lu S, Zhang N, Rong G, Chang X, et al. Downregulated expression of tropomyosin 1 in intrahepatic cholangiocarcinoma: a predictor of recurrence and prognosis. Med Sci Monit. 2018;24:7875\u201382.","journal-title":"Med Sci Monit"},{"issue":"1","key":"1105_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/nano.2006.1.1.15","volume":"1","author":"R Vasita","year":"2006","unstructured":"Vasita R, Katti DS. Nanofibers and their applications in tissue engineering. Int J Nanomed. 2006;1(1):15\u201330.","journal-title":"Int J Nanomed"},{"issue":"8","key":"1105_CR17","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1039\/C9AN01987A","volume":"145","author":"S Asghari","year":"2020","unstructured":"Asghari S, Rezaei Z, Mahmoudifard M. Electrospun nanofibers: a promising horizon toward the detection and treatment of cancer. Analyst. 2020;145(8):2854\u201372.","journal-title":"Analyst"},{"issue":"5","key":"1105_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202100512","volume":"22","author":"SM Costa","year":"2022","unstructured":"Costa SM, Fangueiro R, Ferreira DP. Drug delivery systems for photodynamic therapy: the potentiality and versatility of electrospun nanofibers. Macromol Biosci. 2022;22(5): e2100512.","journal-title":"Macromol Biosci"},{"key":"1105_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","volume":"107","author":"S Thakkar","year":"2017","unstructured":"Thakkar S, Misra M. Electrospun polymeric nanofibers: new horizons in drug delivery. Eur J Pharm Sci. 2017;107:148\u201367.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1105_CR20","first-page":"85","volume":"3","author":"A Akhgari","year":"2013","unstructured":"Akhgari A, Heshmati Z, Sharif MB. Indomethacin electrospun nanofibers for colonic drug delivery: preparation and characterization. Adv Pharm Bull. 2013;3(1):85\u201390.","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"1105_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12951-023-01987-z","volume":"21","author":"K Chen","year":"2023","unstructured":"Chen K, Li Y, Li Y, Tan Y, Liu Y, Pan W, et al. Stimuli-responsive electrospun nanofibers for drug delivery, cancer therapy, wound dressing, and tissue engineering. J Nanobiotechnol. 2023;21(1):237.","journal-title":"J Nanobiotechnol"},{"issue":"16","key":"1105_CR22","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.1021\/acs.jmedchem.5b00910","volume":"58","author":"S Wang","year":"2015","unstructured":"Wang S, Fang K, Dong G, Chen S, Liu N, Miao Z, et al. Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents. J Med Chem. 2015;58(16):6678\u201396.","journal-title":"J Med Chem"},{"key":"1105_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fphar.2018.00130","volume":"9","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Fang T, Zhou H, Yuan J, Liu Q. Characterization of the in vitro metabolic profile of evodiamine in human liver microsomes and hepatocytes by UHPLC-Q exactive mass spectrometer. Front Pharmacol. 2018;9:130.","journal-title":"Front Pharmacol"},{"key":"1105_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120635","volume":"269","author":"SD Allen","year":"2021","unstructured":"Allen SD, Liu X, Jiang J, Liao YP, Chang CH, Nel AE, et al. Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor. Biomaterials. 2021;269: 120635.","journal-title":"Biomaterials"},{"issue":"3","key":"1105_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150195","volume":"11","author":"JB Rose","year":"2016","unstructured":"Rose JB, Correa-Gallego C, Li Y, Nelson J, Alseidi A, Helton WS, et al. The role of biliary carcinoembryonic antigen-related cellular adhesion molecule 6 (CEACAM6) as a biomarker in cholangiocarcinoma. PLoS ONE. 2016;11(3): e0150195.","journal-title":"PLoS ONE"},{"key":"1105_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3389\/fphar.2018.00434","volume":"9","author":"T Su","year":"2018","unstructured":"Su T, Yang X, Deng JH, Huang QJ, Huang SC, Zhang YM, et al. Evodiamine, a novel NOTCH3 methylation stimulator, significantly suppresses lung carcinogenesis in vitro and in vivo. Front Pharmacol. 2018;9:434.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1105_CR27","first-page":"1481","volume":"27","author":"A Rasul","year":"2012","unstructured":"Rasul A, Yu B, Zhong L, Khan M, Yang H, Ma T. Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. Oncol Rep. 2012;27(5):1481\u20137.","journal-title":"Oncol Rep"},{"key":"1105_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117424","volume":"251","author":"S Zhao","year":"2020","unstructured":"Zhao S, Xu K, Jiang R, Li DY, Guo XX, Zhou P, et al. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway. Life Sci. 2020;251: 117424.","journal-title":"Life Sci"},{"issue":"1","key":"1105_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13045-022-01350-z","volume":"15","author":"R Qin","year":"2022","unstructured":"Qin R, You FM, Zhao Q, Xie X, Peng C, Zhan G, et al. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. J Hematol Oncol. 2022;15(1):133.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1105_CR30","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1080\/10717544.2018.1474970","volume":"25","author":"J Zhao","year":"2018","unstructured":"Zhao J, Liu S, Hu X, Zhang Y, Yan S, Zhao H, et al. Improved delivery of natural alkaloids into lung cancer through woody oil-based emulsive nanosystems. Drug Deliv. 2018;25(1):1426\u201337.","journal-title":"Drug Deliv"},{"issue":"4","key":"1105_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/nano9040656","volume":"9","author":"R Contreras-Caceres","year":"2019","unstructured":"Contreras-Caceres R, Cabeza L, Perazzoli G, Diaz A, Lopez-Romero JM, Melguizo C, et al. Electrospun nanofibers: recent applications in drug delivery and cancer therapy. Nanomaterials (Basel). 2019;9(4):656.","journal-title":"Nanomaterials (Basel)"},{"issue":"6","key":"1105_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201701024","volume":"7","author":"S Chen","year":"2018","unstructured":"Chen S, Boda SK, Batra SK, Li X, Xie J. Emerging roles of electrospun nanofibers in cancer research. Adv Healthc Mater. 2018;7(6): e1701024.","journal-title":"Adv Healthc Mater"},{"key":"1105_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.msec.2018.12.105","volume":"97","author":"S Abid","year":"2019","unstructured":"Abid S, Hussain T, Raza ZA, Nazir A. Current applications of electrospun polymeric nanofibers in cancer therapy. Mater Sci Eng C Mater Biol Appl. 2019;97:966\u201377.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"12","key":"1105_CR34","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3390\/pharmaceutics13122054","volume":"13","author":"J Hermosilla","year":"2021","unstructured":"Hermosilla J, Pastene-Navarrete E, Acevedo F. Electrospun fibers loaded with natural bioactive compounds as a biomedical system for skin burn treatment. A review. Pharmaceutics. 2021;13(12):2054.","journal-title":"Pharmaceutics"},{"issue":"9","key":"1105_CR35","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1007\/s11837-022-05180-9","volume":"74","author":"S Mitra","year":"2022","unstructured":"Mitra S, Mateti T, Ramakrishna S, Laha A. A review on curcumin-loaded electrospun nanofibers and their application in modern medicine. JOM. 2022;74(9):3392\u2013407.","journal-title":"JOM"},{"key":"1105_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121990","volume":"624","author":"D Babadi","year":"2022","unstructured":"Babadi D, Dadashzadeh S, Shahsavari Z, Shahhosseini S, Ten Hagen TLM, Haeri A. Piperine-loaded electrospun nanofibers, an implantable anticancer controlled delivery system for postsurgical breast cancer treatment. Int J Pharm. 2022;624: 121990.","journal-title":"Int J Pharm"},{"issue":"1","key":"1105_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1039\/C2TB00121G","volume":"1","author":"S Liu","year":"2013","unstructured":"Liu S, Zhou G, Liu D, Xie Z, Huang Y, Wang X, et al. Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers. J Mater Chem B. 2013;1(1):101\u20139.","journal-title":"J Mater Chem B"},{"key":"1105_CR38","doi-asserted-by":"publisher","first-page":"43271","DOI":"10.1038\/srep43271","volume":"7","author":"R Ramachandran","year":"2017","unstructured":"Ramachandran R, Junnuthula VR, Gowd GS, Ashokan A, Thomas J, Peethambaran R, et al. Theranostic 3-dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma. Sci Rep. 2017;7:43271.","journal-title":"Sci Rep"},{"issue":"1","key":"1105_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2008.10.015","volume":"72","author":"X Xu","year":"2009","unstructured":"Xu X, Chen X, Wang Z, Jing X. Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Eur J Pharm Biopharm. 2009;72(1):18\u201325.","journal-title":"Eur J Pharm Biopharm"},{"key":"1105_CR40","doi-asserted-by":"publisher","first-page":"1724301","DOI":"10.1155\/2022\/1724301","volume":"2022","author":"W Zhu","year":"2022","unstructured":"Zhu W, Zhang X, Yu M, Zhang Y, Li S, Yu C. Profiles of acetylation regulation genes contribute to malignant progression and have a clinical prognostic impact on liver cancer. Dis Markers. 2022;2022:1724301.","journal-title":"Dis Markers"},{"issue":"10","key":"1105_CR41","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/cancers11101587","volume":"11","author":"K Freese","year":"2019","unstructured":"Freese K, Seitz T, Dietrich P, Lee SML, Thasler WE, Bosserhoff A, et al. Histone deacetylase expressions in hepatocellular carcinoma and functional effects of histone deacetylase inhibitors on liver cancer cells in vitro. Cancers (Basel). 2019;11(10):1587.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1105_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41416-022-01805-7","volume":"127","author":"WJ Zang","year":"2022","unstructured":"Zang WJ, Hu YL, Qian CY, Feng Y, Liu JZ, Yang JL, et al. HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3. Br J Cancer. 2022;127(2):237\u201348.","journal-title":"Br J Cancer"},{"issue":"4","key":"1105_CR43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu H, Liu C, Yang Q, Xin C, Du J, Sun F, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy. 2020;16(4):683\u201397.","journal-title":"Autophagy"},{"issue":"2","key":"1105_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41419-021-03417-0","volume":"12","author":"C Cheng","year":"2021","unstructured":"Cheng C, Yang J, Li SW, Huang G, Li C, Min WP, et al. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death Dis. 2021;12(2):137.","journal-title":"Cell Death Dis"},{"key":"1105_CR45","doi-asserted-by":"publisher","first-page":"1116660","DOI":"10.3389\/fmolb.2023.1116660","volume":"10","author":"E Cuttini","year":"2023","unstructured":"Cuttini E, Goi C, Pellarin E, Vida R, Brancolini C. HDAC4 in cancer: a multitasking platform to drive not only epigenetic modifications. Front Mol Biosci. 2023;10:1116660.","journal-title":"Front Mol Biosci"},{"key":"1105_CR46","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.3390\/ijms22137165","volume":"22","author":"S Hakobyan","year":"2021","unstructured":"Hakobyan S, Loeffler-Wirth H, Arakelyan A, Binder H, Kunz M. A transcriptome-wide isoform landscape of melanocytic nevi and primary melanomas identifies gene isoforms associated with malignancy. Int J Mol Sci. 2021;22:7165.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1105_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-021-02707-7","volume":"19","author":"W Liang","year":"2021","unstructured":"Liang W, Wu J, Qiu X. LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1. J Transl Med. 2021;19(1):45.","journal-title":"J Transl Med"},{"key":"1105_CR48","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1158\/1541-7786.MCR-22-0009","volume":"20","author":"C Li","year":"2022","unstructured":"Li C, Hong S, Hu H, Liu T, Yan G, Sun D. MYC-induced upregulation of Lncrna ELFN1-AS1 contributes to tumor growth in colorectal cancer via epigenetically silencing TPM1. Mol Cancer Res. 2022;20:1697\u2013708.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1105_CR49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s13577-020-00453-4","volume":"34","author":"Y Mao","year":"2021","unstructured":"Mao Y, He JX, Zhu M, Dong YQ, He JX. Circ0001320 inhibits lung cancer cell growth and invasion by regulating TNFAIP1 and TPM1 expression through sponging miR-558. Hum Cell. 2021;34(2):468\u201377.","journal-title":"Hum Cell"},{"key":"1105_CR50","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.1073\/pnas.90.15.7039","volume":"90","author":"GL Prasad","year":"1993","unstructured":"Prasad GL, Fuldner RA, Cooper HL. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA. 1993;90:7039\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1105_CR51","first-page":"7060","volume":"15","author":"C Tang","year":"2018","unstructured":"Tang C, Wang J, Wei Q, Du YP, Qiu HP, Yang C, et al. Tropomyosin-1 promotes cancer cell apoptosis via the p53-mediated mitochondrial pathway in renal cell carcinoma. Oncol Lett. 2018;15:7060\u20138.","journal-title":"Oncol Lett"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01105-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:37:22Z","timestamp":1724416642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01105-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01105-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animals were used in protocols approved by the Animal Ethics Committee of the Hainan Cancer Hospital [approval no. 2023 (KY) 016] and in line with the Guide for the Care and Use of Laboratory Animals (NIH).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}